Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Keen, A. C. Olin, S. Eriksson, A. Lindblad, A. Ekman, S. Basu, C. Beermann, B. Strandvik (Gothenburg, Uppsala, Sweden; Friedrichdorf, Germany). Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis. Eur Respir J 2008; 32: Suppl. 52, 3166

Member's Comments

No comment yet.

Related content which might interest you: Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth Source: Eur Respir J 2015; 46: 1033-1045 Year: 2015 Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006 The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 Short-chain fatty acids are potent modulators of allergic airway inflammation Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 Is the unbalance between arachidonic acid and docosahexaenoic acid a reversible condition in adults With cystic fibrosis? Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Effect of dietary nitrite and nitrated fatty acids on airway hyperresponsiveness and inflammation in a mouse model of asthma Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011 Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis Source: Eur Respir J 2007; 29: 958-964 Year: 2007 Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Supplementation with n-3 fatty acids and markers of oxidative stress in elderly exposed to PM2.5 Source: Eur Respir J 2007; 30: Suppl. 51, 630s Year: 2007 Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001 Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodeling Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling Source: Eur Respir J, 58 (5) 2004252; 10.1183/13993003.04252-2020 Year: 2021 Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 Overexpression of fatty acid synthase attenuate bleomycin induced lung injury/fibrosis via restoring mitochondrial dysfunction Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 The effect of dietary fatty acids on inflammation in primary lung mesenchymal cells Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Aging decreases pulmonary fibrosis reversibility via remodeling fatty acid metabolism of fibroblasts modulated by PRDM16 Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020